AzTrials
AzTrials

Problems With Self-assertivenessR2NCT04240249

Constructive Self Assertiveness Via the Internet

A study testing Constructive self-assertiveness program via the internet in people with Problems With Self-assertiveness, run by Stockholm University at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Some people have problems with self-assertiveness. That can have negative impact on their lives. This study will test a constructive self-assertiveness intervention program delivered online. In addition, the relative effect of guidance during the intervention will be investigated. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Problems With Self-assertiveness
What is being tested?
Constructive self-assertiveness program via the internet
Could I receive a placebo?
No, everyone receives an active treatment
How many people
210 participants
Where
1 siteSweden
Study dates
1 Feb 2020to 31 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Human,
  • At least 18 years old,
  • Able to speak and read Swedish,
  • Informed consent.

Who cannot join

  • Severe depression (as defined by a PHQ9 score of 15 points or higher),
  • If on medication the dosage has been stable for at least the past 3 months,
  • No ongoing psychotherapy.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Department of Psychology

    Stockholm, 10691

Other trials in Sweden

About this study

Some people have problems with self-assertiveness. That can have negative impact on their lives. This study will test a constructive self-assertiveness intervention program delivered online. In addition, the relative effect of guidance during the intervention will be investigated.

In a randomized controlled trial three groups will be compared:

  1. constructive self-assertiveness with guidance
  2. constructive self-assertiveness without guidance
  3. Waitlist control
Read the detailed description

Some people have problems with self-assertiveness. That can have negative impact on their lives. This study will test a constructive self-assertiveness intervention program delivered online. In addition, the relative effect of guidance during the intervention will be investigated.

In a randomized controlled trial three groups will be compared:

  1. constructive self-assertiveness with guidance
  2. constructive self-assertiveness without guidance
  3. Waitlist control

The treatment (and wait) will be 10 weeks.

Being tested
Constructive self-assertiveness program via the internet

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Constructive self-assertiveness program via the internetBehavioural

    Participants will get one "chapter" a week to work with. All chapters are presented on web pages and include information and exercises and end with homework assignments.

Study groups in NCT04240249
Study groupRoleWhat they receive
Constructive self-assertiveness with guidanceExperimental10 weeks of internet-based treatment with weekly assignments. The homework is commented on by the guide using electronic communication.
Receives: Behavioral: Constructive self-assertiveness program via the internet
Constructive self-assertiveness without guidanceExperimental10 weeks of internet-based treatment with weekly assignments. The homework is NOT commented on by any guide. Hence, same treatment as group 1 but without guidance.
Receives: Behavioral: Constructive self-assertiveness program via the internet
Waitlist controlNo interventionNo treatment, no guidance, just waiting for 10 weeks. After the ten weeks the participants will receive the treatment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adaptive and Aggressive Assertiveness Scale

    A self-report questionnaire measuring Adaptive and Aggressive Assertiveness. Higher scores mean a worse outcome. Minimum and maximum values: 30-150.

    Measured: Up to 12 months

Secondary outcomes (5)
  1. Patient Health Questionnaire 9-item

    Depression questionnaire. Higher scores mean a worse outcome. Higher scores mean a worse outcome. Minimum and maximum values: 0-27.

    Measured: Up to 12 months

  2. Generalized Anxiety Disorder 7

    General Anxiety questionnaire. Higher scores mean a worse outcome. Minimum and maximum values: 0-27.

    Measured: Up to 12 months

  3. Liebowitz Social Anxiety Scale , self-report

    Social Anxiety questionnaire. Higher scores mean a worse outcome. Minimum and maximum values: 0-144.

    Measured: Up to 12 months

  4. Rathus Assertiveness Schedule

    Assertiveness questionnaire. Higher scores mean a worse outcome. Minimum and maximum values: -30 to +30.

    Measured: Up to 12 months

  5. Well-being scale

    Depression scale. Lower scores mean a worse outcome. Minimum and maximum values: 0-72.

    Measured: Up to 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2020
  2. Study start1 Feb 2020
  3. Primary completion16 May 2021
  4. Study completion31 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A randomized controlled trial with three groups.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
210 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04240249
Sponsor's protocol ID
Respect
Acronym
R2
Status last verified
Apr 2024
First submitted
15 Jan 2020
Last updated
18 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Analytic code and pseudoanonymous data in a data repository.

Publications

  • Hagberg T, Manhem P, Oscarsson M, Michel F, Andersson G, Carlbring P. Efficacy of transdiagnostic cognitive-behavioral therapy for assertiveness: A randomized controlled trial. Internet Interv. 2023 May 13;32:100629. doi: 10.1016/j.invent.2023.100629. eCollection 2023 Apr.

    PubMed 37273933

Questions about this trial

What is this clinical trial studying?

A study testing Constructive self-assertiveness program via the internet in people with Problems With Self-assertiveness, run by Stockholm University at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adaptive and Aggressive Assertiveness Scale (time frame: Up to 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04240249, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in